Navigation Links
UHC to Launch New Specialty Pharmacy Program for Better Continuity of Patient Care, Improved Access to Specialty Pharmaceuticals
Date:9/9/2013

CHICAGO, Sept. 9, 2013 /PRNewswire/ -- Increasing at a rate of more than 20% per year, specialty pharmacy is one of the fastest-growing segments of health care. But hospitals that need specialty pharmaceuticals to perform procedures or treat patients fill less than 1 in 5 of those prescriptions. As a result, the majority of patients must fill their specialty prescriptions elsewhere, including mail-order pharmacies, which are not always convenient for patients and can take patients' care out of the hands of their caregivers.

UHC, an alliance of the nation's leading nonprofit academic medical centers, is unveiling a new specialty pharmacy program in late 2013/early 2014 to provide patients with access to the specialty medications they need at the hospitals where they are treated.

"The UHC specialty pharmacy program will help member hospitals and health systems succeed in an accountable care organization environment in which continuity of care must be available," said Jake Groenewold, UHC senior vice president, Supply Chain. "A patient's health care team must coordinate care and services among inpatient settings, outpatient settings, infusion clinics, and pharmacies."

In a real-life example of how this program will improve continuity of care for the patient, a member hospital worked with a patient whose copayment for a specialty medication had more than tripled. As the patient applied for assistance through the pharmaceutical company, the patient's specialty pharmacy withheld her prescription. Her physician worked with the hospital pharmacist to assist the patient and found a lower-cost generic specialty medication with an affordable copayment that the hospital could fill. The patient missed only 1 day of her prescribed follow-up medication, minimizing the potential for worsening symptoms and avoiding hospitalization. Without a specialty pharmacy program in place, the hospital may not have been able to act as quickly to help the patient.

A key element of the UHC specialty pharmacy program is a UHC-controlled data repository. UHC will track patient outcomes using its access to medical record data to provide clinical evidence for promoting the best therapeutic regimens. UHC will also identify patients who have a failed or unsustainable response to therapy and would be good candidates for a newly approved and potentially lifesaving medication.

"This program provides the foundation for UHC to become the industry leader in reducing the time to initiate therapy, ensuring patient safety, and improving adherence," said Groenewold. "Patients still get their access to top specialists but will now receive more convenient access to the specialty medications they need."

The UHC specialty pharmacy program is the latest offering in the UHC Supply Chain Intelligence™ suite of programs designed to meet the needs of academic medical centers and affiliated organizations. As the program develops, additional information will be made available, including an announcement at the American Society of Health-System Pharmacists Midyear Clinical Meeting in December 2013.

About UHC
UHC is an alliance of the nation's leading nonprofit academic medical centers, which are focused on delivering world-class patient care. Based in Chicago, Ill, UHC fosters collaboration with and among its 118 academic medical center and 298 affiliated hospital members through its renowned programs and services in the areas of comparative data and analytics, performance improvement, supply chain management, strategic research, and public policy. UHC helps its members achieve excellence in quality, safety, and cost-effectiveness. Formed in 1984, UHC's membership includes the leading nonprofit academic medical centers in the United States. For more information, visit uhc.edu.


'/>"/>
SOURCE UHC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
6. American Academy of Family Physicians Foundation Launches Cities for Life
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
11. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... New ... of ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. ... direct cost savings as well as more stable pricing over time. Now it’s ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, a medical ... that it has received 510(k) clearance from the U.S. Food & Drug Administration ... Pro. , Both devices are stationary cycling systems that use MYOLYN’s patent-pending ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... CFOs and HR decision-makers are preparing for how his administration could impact the ... provide insight into what changes are most likely to make it through Congress. ...
Breaking Medicine News(10 mins):